Request Demo
Last update 01 Apr 2025
AWD.pharma GmbH & Co. KG
Last update 01 Apr 2025
Overview
Tags
Cardiovascular Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
EUCTR2009-013268-38-DE
A multicentre, double-blind, randomised, active- and placebo-controlled clinical trial on the pain relieving effects of the modfied-release formulation of flupirtine in patients suffering from moderate to severe chronic low back pain
NCT01676246
Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine After Intravenous, Single Dose and Chronic Oral Administration in Healthy Subjects Genotyped for NAT2, UGT1A1 and GSTP1
EUCTR2005-002959-41-DE
A multicentre, double-blind, randomised, placebo-controlled clinical trial to investigate pain relieving effects of the modified release (MR) formulation of flupirtine in patients suffering from moderate to severe chronic low back pain.
100 Clinical Results associated with AWD.pharma GmbH & Co. KG
Login to view more data
Login to view more data
01 Nov 2008MMW Fortschritte der Medizin
AT1-Antagonist bewährt sich auch im Praxisalltag
Article
Author: Baumhäkel, Magnus ; Müller, Ulrike
01 Jun 2001Die PharmazieQ4 · MEDICINE
Identität und physikochemische Eigenschaften von 1-(4-Chlorphenyl)-4-morpholino-imidazolin-2-on, AWD 131-138.
Q4 · MEDICINE
Article
Author: Heinecke, K ; Thiel, W
01 Nov 2000Die Pharmazie
Article
Author: Heinecke, K ; Poppe, H ; Schindler, R ; Szelenyi, I ; Hoefgen, N
100 Deals associated with AWD.pharma GmbH & Co. KG
Login to view more data
100 Translational Medicine associated with AWD.pharma GmbH & Co. KG
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 27 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free